Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 31.18B | 37.31B | 30.40B | 22.92B | 21.30B |
Gross Profit | 11.09B | 14.72B | 10.23B | 6.41B | 5.62B |
EBITDA | 9.47B | 11.59B | 8.69B | 4.42B | 4.96B |
Net Income | 5.75B | 7.30B | 5.40B | 3.04B | 2.50B |
Balance Sheet | |||||
Total Assets | 81.39B | 87.80B | 72.55B | 62.61B | 58.72B |
Cash, Cash Equivalents and Short-Term Investments | 17.42B | 22.34B | 19.37B | 22.44B | 16.63B |
Total Debt | 9.00M | 1.00M | 7.00M | 17.00M | 30.00M |
Total Liabilities | 7.59B | 14.90B | 10.14B | 6.55B | 5.25B |
Stockholders Equity | 73.79B | 72.88B | 62.40B | 56.05B | 53.47B |
Cash Flow | |||||
Free Cash Flow | -2.00B | 4.54B | 34.00M | 6.80B | 1.45B |
Operating Cash Flow | 4.55B | 7.79B | 2.34B | 7.62B | 3.37B |
Investing Cash Flow | -5.40B | -16.03B | -4.35B | -954.00M | -1.94B |
Financing Cash Flow | -2.99B | -1.39B | -1.03B | -826.00M | -1.03B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥46.44B | 19.64 | 3.26% | 11.94% | 17.08% | ||
73 Outperform | ¥43.10B | 10.11 | 4.78% | -27.68% | -43.78% | ||
73 Outperform | ¥47.63B | 9.39 | 4.78% | 0.10% | ― | ||
70 Outperform | ¥179.59B | 11.19 | 5.69% | 3.10% | 2.78% | -8.64% | |
69 Neutral | $46.11B | 11.31 | 7.92% | 4.79% | -2.88% | -6.99% | |
68 Neutral | ¥22.73B | 9.03 | 3.74% | -1.44% | -1.26% | ||
56 Neutral | $217.57B | 19.46 | -16.22% | 2.94% | -5.38% | -491.67% |